Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

BAN-CANCER

Financiado

Cerrado

Smart Bandage for Cancer Margin Theranostics

"Successful surgical treatment of breast cancer crucially depends on accurate detection of the boundaries between malignant and healthy cells (tumor margins) and is a major determinant of patient survival. The current standard for... ver más

30/06/2015

IMPERIAL COLLEGE O...

209K€

Presupuesto del proyecto: 209K€

Líder del proyecto

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND ME... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2015-06-30 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

IMPERIAL COLLEGE OF SCIENCE...

0.00€ | Lider

Proyectos interesantes

STRIKE

Medical Technol...

Nanotechnology

Cerrado

RBCE-GENODIAGNOSENS

Medical Technol...

Nanotechnology

159K€ Cerrado

NANOEYE

Medical Technol...

Nanotechnology

240K€ Cerrado

HypoSens

Medical Technol...

Nanotechnology

4M€ Cerrado

EUIN2015-62619

Nanotechnology

Medical Technol...

10K€ Cerrado

DIAG-CANCER

Medical Technol...

Nanotechnology

1M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND ME... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 209K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "Successful surgical treatment of breast cancer crucially depends on accurate detection of the boundaries between malignant and healthy cells (tumor margins) and is a major determinant of patient survival. The current standard for assessment of margins is the evaluation by the surgeon in the operating room followed by histological sampling. The project smart BANdage for CANCER margin theranostics (BAN-CANCER) combines diagnosis of malignancy at the single cell level over a large area with stimuli-responsive delivery of therapy in a theranostic device for intraoperative detection and eradication of malignant cells at breast tumor margins. BAN-CANCER is a multidisciplinary project that combines the potential of nanoscale materials with a novel theranostic approach. It constitutes a leap forward with respect to current and proposed diagnostics, allowing to diagnose and treat breast carcinoma margin involvement for the first time (i) intraoperatively (ii) at the single cell level (iii) over the entire surgical incision; in a (iv) simple, (v) inexpensive,(vi) biocompatible package; that can be (vii) routinely employed by surgeons without requiring (viii) added equipment or (ix) prolonged analysis. BAN-CANCER will consist of a vertical array of porous silicon nanoneedles sticking out from a flexible substrate over several square cm. The gauze will be applied over the margins of the remaining breast epithelium following tumor excision allowing the nanoneedles to penetrate within each cell. The needles will be functionalized to release a fluorescent chemotherapy drug in response of abnormal cytosolic protease activity to provide simultaneous imaging and eradication of cancer cells. When the gauze will be removed the surgeon will assess the extent of margin involvement and make an informed decision extending the excision. The intracellular release of chemotherapy will ensure the death of isolated, difficult to observe cancer cells, further preventing recurrence."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores